Distinctiveness of Nanoparticles Drug Delivery in Cancer

Authors

  • Dr. A. Mohamed Sikkander
  • Dr. K. Kavitha
  • Ms. S. Sasikala
  • Dr. Khadeeja Yasmeen

DOI:

https://doi.org/10.46243/jst.2021.v6.i2.pp17-22

Keywords:

Avascular Tumor, Cancer diagnosis, Drug Delivery, Nanomedicine, Vascular Tumor

Abstract

Nanomedicine is the effect of advances in Nanoscience and nanotechnology and is normally referred to as biotechnology applications in Nanoscience and nanotechnology. Also, the Nanomedicine development of fields of analysis and treatment in biological systems at the cellular and sub-cellular levels has provided revolutionary methods for the recognition and deterrence of certain fatal diseases. For example, the National Cancer Institute of America expects nanotechnology and Nanoscience to be used to manage cancer and thus reduce mortality. Because of the closeness of Nanoscience to fertility, the US Department of the Food and Drug direction has been exploring the complex issues associated with nanoscale testing, nanoparticles, and Nanosystems to get better human life. Nanoscale resources can be described as a range of atoms up to 100 nanometers, and almost a nanoscale substance is defined as a material with the smallest dimensions of less than 100 nanometers.

Downloads

Published

2021-02-03

How to Cite

Dr. A. Mohamed Sikkander, Dr. K. Kavitha, Ms. S. Sasikala, & Dr. Khadeeja Yasmeen. (2021). Distinctiveness of Nanoparticles Drug Delivery in Cancer. Journal of Science & Technology (JST), 6(2), 17–22. https://doi.org/10.46243/jst.2021.v6.i2.pp17-22